Association of achieved LDL-C levels with global coagulability and clinical outcomes in patients with acute coronary syndrome receiving PCSK9 inhibitors: a prospective cohort study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Target LDL-C Levels on Global Coagulability and Clinical Outcomes in Acute Coronary Syndrome Patients Treated with PCSK9 Inhibitors: Findings from a Prospective Cohort Study

  • By

  • Tianfu Fu

  • Song Yao

  • Shaojiang Zhang

  • Hui Linghu

  • June 10, 2026

Share

Original Source(s)

Related Content